Business Wire - Auriga Laboratories Obtains Rights to Market and Sell an FDA-Approved Product Indicated for the Treatment of Mild to Moderately Severe Pain

Published on: Mon, 05 Nov 2007 08:00:00 GMT

November 5, 2007 -- LOS ANGELES -- Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company building the first nationwide, commission-only... More »